PacBio
IPOSequence with confidence.
Public · USA, United States · Founded 2004 · $109.0M raised
- Headquarters
- USA, California
- Employees
- 501–1000
- Founded
- 2004
- Business Model
- B2B
- Website
- pacb.com
- Total Funding
- $109.0M
- Last Round
- $109.0M Series FJul 2010
- Rounds
- 1
- Type
- Public
About
PacBio (Pacific Biosciences) develops and manufactures advanced long-read DNA sequencing systems used by researchers worldwide. The company's HiFi sequencing technology delivers 99.9% accuracy across long reads, enabling comprehensive analysis of genomes, transcriptomes, and epigenomes. PacBio serves genomics researchers in human health, agriculture, infectious disease, and biopharma, with its Revio and Vega systems as flagship platforms.
Summary
PacBio is a Biotech company based in USA, United States, founded in 2004. It has raised $109.0M in total across 1 round, most recently a $109.0M Series F round in Jul 2010. Investors include SoftBank.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png)
Similar Companies
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.